Imrab 1 - 1905.21

21 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1900.0%

Death Rate

Active Ingredients

Imrab 1 - 1905.21

Administration Routes

SubcutaneousUnknown

Species Affected

Dog 21

Most Affected Breeds

Crossbred Canine/dog 3

Retriever - Labrador 3

Dog (other) 2

Terrier - Boston 2

Retriever - Golden 2

Shih Tzu 2

Pug 2

Dachshund - Miniature 1

Rottweiler 1

Schnauzer (unspecified) 1

Most Reported Reactions

Vomiting 6

Other abnormal test result NOS 5

Leucocytosis NOS 3

Seizure NOS 3

Emesis 3

Lethargy (see also Central nervous system depression in 'Neurological') 2

Scratching 2

Facial swelling (see also 'Skin') 2

Anaphylactoid reaction 2

Hives (see also 'Skin') 2

Death 2

Shaking 2

Outcome Breakdown

Outcome Unknown

9 (42.9%)

Recovered/Normal

5 (23.8%)

Ongoing

3 (14.3%)

Died

2 (9.5%)

Euthanized

2 (9.5%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.